Mats Johan Peter Thorén
Directeur/Membre du Conseil chez BIOPORTO A/S
Fortune : 4 342 $ au 30/04/2024
Postes actifs de Mats Johan Peter Thorén
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARCOMA AB | Directeur/Membre du Conseil | 01/01/2012 | - |
Independent Dir/Board Member | 01/01/2012 | - | |
HERANTIS PHARMA OYJ | Directeur/Membre du Conseil | 11/03/2020 | - |
Independent Dir/Board Member | 11/03/2020 | - | |
FLUOGUIDE A/S | Directeur/Membre du Conseil | 01/01/2021 | - |
Independent Dir/Board Member | 01/01/2021 | - | |
XBRANE BIOPHARMA AB | Directeur/Membre du Conseil | 01/01/2020 | - |
Independent Dir/Board Member | 01/01/2020 | - | |
BIOPORTO A/S | Directeur/Membre du Conseil | 30/04/2024 | - |
C-RAD AB | Directeur/Membre du Conseil | 15/05/2024 | - |
Independent Dir/Board Member | 15/05/2024 | - | |
Arcoma Incentive AB | Directeur/Membre du Conseil | - | - |
Pulsetten AB | Directeur/Membre du Conseil | - | - |
Vixco Capital AB
Vixco Capital AB Insurance Brokers/ServicesFinance Vixco Capital AB offers consultancy services within managing and financing of risk capital investments. The company is headquartered in Stockholm, Sweden. | Directeur Général | 17/07/2008 | - |
Fondateur | 17/07/2008 | - |
Historique de carrière de Mats Johan Peter Thorén
Anciens postes connus de Mats Johan Peter Thorén
Sociétés | Poste | Début | Fin |
---|---|---|---|
░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Mats Johan Peter Thorén
Stockholm School of Economics | Undergraduate Degree |
Karolinska Institutet | Undergraduate Degree |
Statistiques
Internationale
Suède | 20 |
Danemark | 3 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 16 |
Independent Dir/Board Member | 5 |
Corporate Officer/Principal | 3 |
Sectorielle
Health Technology | 9 |
Finance | 7 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 8 |
---|---|
ARCOMA AB | Health Technology |
ATTANA AB | Health Services |
C-RAD AB | Health Technology |
MEDCAP AB | Health Technology |
HERANTIS PHARMA OYJ | Health Technology |
FLUOGUIDE A/S | Health Technology |
XBRANE BIOPHARMA AB | Health Technology |
BIOPORTO A/S | Health Technology |
Entreprise privées | 13 |
---|---|
Millicore AB
Millicore AB Electronic Equipment/InstrumentsElectronic Technology Millicore AB provides medical technology solutions. It is engaged in the business of development and commercialization of MEMS-based digital disposable products for the healthcare industry. The company was founded in 2003 and is headquartered in Stockholm, Sweden | Electronic Technology |
MIP Technologies AB
MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides. | Commercial Services |
Catella Healthcare AB
Catella Healthcare AB Investment ManagersFinance Part of Catella AB, Catella Healthcare AB is an alternative investment manager. The company is based in Stockholm, Sweden. | Finance |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Skandinaviska Enskilda Banken AB (Broker)
Skandinaviska Enskilda Banken AB (Broker) Investment Banks/BrokersFinance Skandinaviska Enskilda Banken AB (Broker) (SEB-Broker) is the broker/dealer division of Skandinaviska Enskilda Banken AB (STO: SEB-A; OTCMKTS: SVKEF), a financial group headquartered in Stockholm, Sweden. Founded in 1856, SEB-Broker provides trading and executions services to their clients. | Finance |
Vixco Capital AB
Vixco Capital AB Insurance Brokers/ServicesFinance Vixco Capital AB offers consultancy services within managing and financing of risk capital investments. The company is headquartered in Stockholm, Sweden. | Finance |
IMIX Holding AB
IMIX Holding AB MiscellaneousMiscellaneous IMIX Holding AB is a holding Swedish company. The private company is based in Växjö, Sweden and has subsidiaries in Finland. The CEO of the company is Per Jonas Salomonson. | Miscellaneous |
Enskilda Securities AB
Enskilda Securities AB Investment Banks/BrokersFinance Enskilda Securities AB is based in Stockholm, Sweden. Enskilda Securities AB, now known as SEB, is a bank that provides advice and long-term relationships to both individuals and businesses to help them succeed. Enskilda Securities was acquired by Skandinaviska Enskilda Banken AB from Orkla ASA on April 04, 2003 for $94.21 million. | Finance |
Svenska Handelsbanken AB (Broker)
Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives. | Finance |
Inter Life Science AB
Inter Life Science AB Financial ConglomeratesFinance Part of Catella AB, Inter Life Science AB is a Swedish company that provides investment services. The company is based in Stockholm, Sweden and was founded in 2004. | Finance |
Pulsetten AB | |
Arcoma Incentive AB | |
DuoCort AB
DuoCort AB Pharmaceuticals: MajorHealth Technology DuoCort AB manufactures pharmaceutical products. The company is based in Helsingborg, Sweden. The Swedish company was founded by Thomas Hedner. | Health Technology |
- Bourse
- Insiders
- Mats Johan Peter Thorén
- Expérience